The role of thyroid hormone deiodination in the regulation of hypothalamo-pituitary function
Abstract
There is extensive deiodinative metabolism of thyroxine (T4) in thyroid hormone target organs, including the pituitary and brain. In both rat and man, most of the 3,3’,5-triiodothyronine (T3) in the body is produced outside the thyroid gland by deiodination of T4. T3 is the principal active form of thyroid hormone within cells. In the rat, there are at least three enzymatic iodothyronine-deiodinating pathways which can be distinguished by kinetics and substrate and inhibitor specificities. Two of these (types I and II) can convert T4 to T3.The third pathway (type III) converts T4 to the inactive reverse-T3 and T3 to an inactive diiodothyronine. Both the anterior pituitary and the brain produce most of their intracellular T3 locally, by the type-II pathway. Type-Ill activity is present throughout the brain, but not in the anterior pituitary. Studies in the rat, using the deiodination inhibitor iopanoic acid, show that the capacities of T4 to inhibit thyrotropin release and stimulate growth hormone synthesis require conversion of T4 to T3 in the pituitary. Studies in man strongly suggest that the same is true in the human adenohypophysis, and a syndrome in man of a deficiency in this process possibly exists. The hypothalamus exhibits some responses to thyroid hormone, including changes in somatostatin and substance P content and changes in activities of type-II and III deiodination. The mechanism(s) of action of thyroid hormone in the hypothalamus, and in the brain in general, are not yet well understood. Speculations are advanced that modulation of type-II deiodination in the pituitary and hypothalamus could serve as a defense against thyroid hormone deficiency, that type-Ill deiodination could act together with type-II deiodination to control brain T3 content, and that local reverse-T3 production in the brain by the type-III pathway might have some, as yet unidentified, physiological significance. Further work in this field is likely to elucidate both mechanisms of control of pituitary hormone secretion and mechanisms of action of thyroid hormone.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The validity of the novel human cell model was supported by expression of MCT8, additional TH transporters LAT1, LAT2, MCT10, lower levels of OATP1C1, and DIO3.
“The validity of this novel human cell model was supported by the expression of MCT8, along with additional TH transporters LAT1, LAT2, MCT10, and lower levels of OATP1C1, as well as the main human cerebral deidodinase DIO3 (Kaplan, 1984).”
From Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier (2017) · cites this paper as Kaplan, 1984
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
Cited by 126
- Authors
- Kaplan, M. M.
- Corresponding author
- Kaplan, Michael M.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-03-28
- Volume
- 38
- Issue
- 3
- Pages
- 254-260
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2071064342
- Cited by
- 126
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 1 · 2021: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid hormone deiodination, type 2 deiodinase, thyroxine to triiodothyronine conversion, reverse T3, diiodothyronine, anterior pituitary, hypothalamus, thyrotropin release, growth hormone synthesis, iopanoic acid, somatostatin, substance P, thyroid hormone deficiency
- MeSH terms
- Animals, Brain, Humans, Hypothalamo-Hypophyseal System, Hypothalamus, Hypothyroidism, Iodide Peroxidase, Median Eminence, Peroxidases, Pituitary Gland, Anterior, Thyroid Hormones, Thyroxine, Triiodothyronine, Triiodothyronine, Reverse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review